Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0500 CAD | +42.86% |
|
-.--% | +25.00% |
Capitalization | 11.22M 8.2M 7.12M 6.7M 6.09M 709M 12.57M 78.65M 30.4M 324M 30.77M 30.11M 1.19B | P/E ratio 2022 |
-2.06x | P/E ratio 2023 | -1.7x |
---|---|---|---|---|---|
Enterprise value | 9.84M 7.19M 6.24M 5.87M 5.34M 621M 11.03M 68.98M 26.66M 284M 26.98M 26.41M 1.04B | EV / Sales 2022 |
10.3x | EV / Sales 2023 | 2.18x |
Free-Float |
94.94% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Numinus Wellness Inc.
More press releases
1 day | +42.86% | ||
6 months | +25.00% | ||
Current year | +25.00% |
Current year | 0.04 | ![]() | 0.05 |
1 year | 0.02 | ![]() | 0.11 |
3 years | 0.02 | ![]() | 0.41 |
5 years | 0.02 | ![]() | 2.45 |
10 years | 0.02 | ![]() | 2.45 |
Manager | Title | Age | Since |
---|---|---|---|
Michael Tan
CEO | Chief Executive Officer | - | 2025-01-22 |
Paul Thielking
CTO | Chief Tech/Sci/R&D Officer | - | 2022-06-09 |
Evan Wood
CTO | Chief Tech/Sci/R&D Officer | - | 2020-05-20 |
Director | Title | Age | Since |
---|---|---|---|
Payton Nyquvest
CHM | Chairman | - | 1962-06-25 |
Michael Tan
BRD | Director/Board Member | - | 2020-05-14 |
Larry Timlick
BRD | Director/Board Member | 68 | 2019-01-27 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+42.86% | -.--% | -.--% | -83.05% | 11.78M | ||
-0.04% | -3.02% | +17.32% | +12.55% | 48.38B | ||
-18.96% | +285.80% | +58,645.35% | +5,549.30% | 31.33B | ||
-0.45% | -3.61% | +63.51% | +91.43% | 32.21B | ||
+0.33% | -2.66% | -27.36% | -21.50% | 26.75B | ||
+0.31% | +0.06% | -1.04% | +20.47% | 26.19B | ||
-0.23% | +1.48% | +13.47% | -17.84% | 12.52B | ||
-1.48% | -2.41% | +127.74% | - | 11.96B | ||
+1.11% | -1.45% | -54.99% | -28.60% | 11.41B | ||
-1.27% | -0.59% | +38.57% | +103.42% | 10.31B | ||
Average | +2.41% | +37.11% | +5,882.26% | +625.13% | 21.11B | |
Weighted average by Cap. | -2.80% | +54.93% | +8,720.85% | +893.31% |
2022 | 2023 | |
---|---|---|
Net sales | 6.49M 4.75M 4.12M 3.88M 3.52M 410M 7.28M 45.53M 17.59M 188M 17.81M 17.43M 686M | 23.18M 16.94M 14.71M 13.84M 12.57M 1.46B 25.98M 163M 62.8M 670M 63.57M 62.22M 2.45B |
Net income | -44.88M -32.8M -28.48M -26.8M -24.35M -2.83B -50.3M -315M -122M -1.3B -123M -120M -4.74B | -30.26M -22.11M -19.2M -18.07M -16.41M -1.91B -33.91M -212M -81.97M -874M -82.97M -81.21M -3.2B |
Net Debt | -25.19M -18.41M -15.99M -15.04M -13.67M -1.59B -28.23M -177M -68.26M -728M -69.09M -67.62M -2.66B | -1.38M -1.01M -876K -824K -749K -87.17M -1.55M -9.68M -3.74M -39.87M -3.78M -3.7M -146M |
More financial data
* Estimated data
Employees
-
Calendar
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NUMI Stock
Select your edition
All financial news and data tailored to specific country editions